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The Ca2+-binding protein of the EF-hand type, S100B, is abundantly expressed in 
and released by astrocytes, and leakage of S100B from damaged astrocytes occurs dur-
ing the course of acute and chronic brain disorders [1]. Thus, the concept has emerged 
that S100B might act an unconventional cytokine or a damage-associated molecular pat-
tern protein playing a role in the pathophysiology of neurodegenerative disorders and 
inflammatory brain diseases. S100B’s pro-inflammatory effects require relatively high 
concentrations of the protein, while at physiological concentrations S100B exerts trophic 
effects on neurons. Most, if not all of the extracellular (trophic and toxic) effects of S100B 
in the brain are mediated by the engagement of RAGE (receptor for advanced glycation 
end products) [1-2]. For example, high S100B activates RAGE-dependently microglia, 
stimulating the release of IL-1β and TNF-α and upregulating the expression of the pro-
inflammatory enzyme, COX-2 [3-4]. We show here that high S100B chemoattracts mu-
rine microglia via RAGE engagement and RAGE-dependent activation of Src kinase, 
Ras, PI3K, MEK/ERK1/2, RhoA/ROCK, Rac1/JNK/AP-1, Rac1/NF-κB and, to a lesser 
extent, p38 MAPK. Recruitment of the adaptor protein, diaphanous-1, a member of the 
formin protein family, is also required for S100B/RAGE-dependent chemoattraction of 
microglia. The S100B/RAGE-dependent activation of diaphanous-1/Rac1/JNK/AP-1, 
Ras/Rac1/NF-κB and, likely, Src/Ras/PI3K/RhoA/diaphanous-1 results in the upreg-
ulation of expression of the chemokines, CCL3, CCL5 and CCL12, the release and activ-
ity of which are required for S100B to chemoattract microglia. Lastly, RAGE engagement 
by S100B in microglia results in upregulation of the chemokine receptors, CCR1 and 
CCR5. These results suggests that S100B might participate in the pathophysiology of 
brain inflammatory disorders via RAGE-dependent regulation of several inflammation-
related events including attraction and activation of microglia.
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